Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q3

3750.TEDINET S100STK6
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥1.4bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥2.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.7bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income−¥495m2023-04-01 → 2023-12-31Cons.Operating income
Operating income−¥516m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income−¥595m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income−¥862m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥602m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥533m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax−¥710m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥553m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥723m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥552m2023-04-01 → 2023-12-31Cons.Profit loss
Net income−¥723m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥13.7bnat 2023-12-31Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.1bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥11.6bnat 2023-12-31Cons.Liabilities
Total liabilities¥11.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥2.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥2.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.0bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥716mat 2023-12-31Cons.Cash and deposits
Cash and deposits¥1.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-61.92023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-30.312023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-118.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-80.952022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.092022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio13.7%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio17.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥134m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2023-04-01 → 2023-12-31¥102m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2023-04-01 → 2023-12-31¥102m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2023-04-01 → 2023-12-31−¥418m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2023-04-01 → 2023-12-31¥1.3bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.3bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2023-04-01 → 2023-12-31¥58m
—segment totalrevenue2023-04-01 → 2023-12-31¥1.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥1.4bn
—segment totalsegment profit2023-04-01 → 2023-12-31−¥360m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥116m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-12-31−¥224m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-12-31−¥176m
—segment totalrevenue2022-04-01 → 2022-12-31¥1.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥1.7bn
—segment totalsegment profit2022-04-01 → 2022-12-31−¥400m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 333
ItemContextValueUnit
Long term loans payablePrior1YearInstant7605855000JPY
Long term loans payableCurrentQuarterInstant6843099000JPY
Investments in silent partnerships nclPrior1YearInstant1078884000JPY
Investments in silent partnerships nclCurrentQuarterInstant1062602000JPY
Deferred tax liabilitiesPrior1YearInstant1436377000JPY
Deferred tax liabilitiesCurrentQuarterInstant1454356000JPY
Other nclPrior1YearInstant140212000JPY
Other nclCurrentQuarterInstant43417000JPY
Noncurrent liabilitiesPrior1YearInstant10261328000JPY
Noncurrent liabilitiesCurrentQuarterInstant9403475000JPY
LiabilitiesPrior1YearInstant11434953000JPY
LiabilitiesCurrentQuarterInstant11634572000JPY
Capital stockPrior1YearInstant100000000JPY
Capital stockCurrentQuarterInstant100000000JPY
Capital surplusPrior1YearInstant2939268000JPY
Capital surplusCurrentQuarterInstant2939268000JPY
Retained earningsPrior1YearInstant-596921000JPY
Retained earningsCurrentQuarterInstant-1149556000JPY
Treasury stockPrior1YearInstant-1240000JPY
Treasury stockCurrentQuarterInstant-1375000JPY
Shareholders equityPrior1YearInstant2441106000JPY
Shareholders equityCurrentQuarterInstant1888336000JPY
Valuation difference on available for sale securitiesPrior1YearInstant66000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant163000JPY
Valuation and translation adjustmentsPrior1YearInstant66000JPY
Valuation and translation adjustmentsCurrentQuarterInstant163000JPY
Subscription rights to sharesPrior1YearInstant211501000JPY
Subscription rights to sharesCurrentQuarterInstant211501000JPY
Non controlling interestsPrior1YearInstant4007000JPY
Non controlling interestsCurrentQuarterInstant4535000JPY
Net assetsPrior1YearInstant2656682000JPY
Net assetsCurrentQuarterInstant2104537000JPY
Liabilities and net assetsPrior1YearInstant14091635000JPY
Liabilities and net assetsCurrentQuarterInstant13739109000JPY
Net salesPrior1YTDDuration1651836000JPY
Net salesCurrentYTDDuration1411589000JPY
Cost of salesPrior1YTDDuration737921000JPY
Cost of salesCurrentYTDDuration255619000JPY
Gross profitPrior1YTDDuration913914000JPY
Gross profitCurrentYTDDuration1155969000JPY
Selling general and administrative expensesPrior1YTDDuration1429743000JPY
Selling general and administrative expensesCurrentYTDDuration1650601000JPY
Operating incomePrior1YTDDuration-515828000JPY
Operating incomeCurrentYTDDuration-494631000JPY
Insurance income noiPrior1YTDDuration－JPY
Insurance income noiCurrentYTDDuration3085000JPY
Subsidy income noi bountyPrior1YTDDuration22758000JPY
Subsidy income noi bountyCurrentYTDDuration1300000JPY
Interest subsidy noiPrior1YTDDuration4527000JPY
Interest subsidy noiCurrentYTDDuration4259000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass